Mustang Bio (MBIO) Secures $9.28M Grant to Fund Ongoing Phase 1 Clinical Trial of MB-103 (HER2-Specific CAR T Cells)

August 13, 2019 8:04 AM

Mustang Bio, Inc. (NASDAQ: MBIO) today announced that City of Hope has received a $9.28 million grant from the California ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found